Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
2008-4-28
pubmed:abstractText
Interleukin-31 (IL-31), an IL-6 cytokine family member, is proposed to play a role in animal models of airway hyperreactivity. It is produced by activated T cells and signals via a heterodimeric receptor complex composed of IL-31Ralpha and OSMRbeta. Only low levels of IL-31Ralpha expression have been demonstrated in pulmonary epithelial cell lines, however, and little is known about the ability to regulate its expression and signaling. Therefore, primary cultures of human bronchial and alveolar epithelial cells, pulmonary fibroblasts, pulmonary macrophages, and established lines of immortalized bronchial epithelial cells (HBE) and alveolar carcinoma cells (A549) were analyzed by RT-PCR, immunoblotting, and thymidine incorporation. Distinct, cell type-specific regulation of IL-31Ralpha expression was detected. Transforming growth factor-beta (TGF-beta) enhanced IL-31Ralpha mRNA expression in primary cultures and established lines of epithelial cells, but not in macrophages. In contrast, interferon-gamma (IFN-gamma) induced IL-31Ralpha mRNA expression in macrophages. IL-31Ralpha protein expression was below detection threshold in primary epithelial cell cultures but was detectable in A549 cells and increased with TGF-beta treatment. In HBE and A549 cells, TGF-beta pretreatment increased IL-31-mediated Stat3 and extracellular signal-regulated kinase 1/2 (ERK1/2) phosphorylation. In A549 cells, TGF-beta magnified IL-31-dependent suppression of proliferation. The data suggest that increased IL-31Ralpha expression correlates with an enhanced response to IL-31.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
1079-9907
pubmed:author
pubmed:issnType
Print
pubmed:volume
28
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
207-19
pubmed:meshHeading
pubmed-meshheading:18439099-Bronchi, pubmed-meshheading:18439099-Cell Proliferation, pubmed-meshheading:18439099-Cells, Cultured, pubmed-meshheading:18439099-Culture Media, Conditioned, pubmed-meshheading:18439099-DNA, pubmed-meshheading:18439099-Dexamethasone, pubmed-meshheading:18439099-Epithelial Cells, pubmed-meshheading:18439099-Fibroblasts, pubmed-meshheading:18439099-Gene Expression Regulation, pubmed-meshheading:18439099-Humans, pubmed-meshheading:18439099-Immunoblotting, pubmed-meshheading:18439099-Macrophages, Alveolar, pubmed-meshheading:18439099-Pulmonary Alveoli, pubmed-meshheading:18439099-RNA, Messenger, pubmed-meshheading:18439099-Receptors, Interleukin, pubmed-meshheading:18439099-Reverse Transcriptase Polymerase Chain Reaction, pubmed-meshheading:18439099-Signal Transduction, pubmed-meshheading:18439099-Transforming Growth Factor beta
pubmed:year
2008
pubmed:articleTitle
Regulated expression of the IL-31 receptor in bronchial and alveolar epithelial cells, pulmonary fibroblasts, and pulmonary macrophages.
pubmed:affiliation
Department of Surgery, SUNY Buffalo, Buffalo, NY 14203, USA. rjawa@unmc.edu
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't, Research Support, N.I.H., Extramural